Sterile Compounding Pharmacies Market Size & Growth Report 2028

Sterile Compounding Pharmacies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Injectable Drugs and Infusions) and Route of Administration (Intravenous, Intramuscular, and Subcutaneous), and Geography

  • Report Code : TIPRE00026302
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 163
Buy Now

Sterile Compounding Pharmacies Market Size & Growth Report 2028

Buy Now

[Research Report] The sterile compounding pharmacies market is projected to reach US$ 6,198.59 million by 2028 from US$ 3,968.70 million in 2021; it is expected to grow at a CAGR of 6.6% from 2021 to 2028.

Factors such as the rise in the uptake of personalized medicines and the benefits associated with on-site sterile compounding drive the growth of the market. However, product recalls and stringent regulatory requirements impede market growth. On the other hand, the development of centralized or regional compounding centers for customized formulations would create lucrative opportunities for market growth during the forecast period.

North America is likely to continue its dominance in the sterile compounding pharmacies market during 2021–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period. This is primarily attributed to the rising pharmaceutical spending and the well-established healthcare infrastructure. For example, the Food and Drug Administration (FDA) has designated 503B (For records, 503B is referred to as an outsourcing facility and is sometimes referred to as 503B pharmacies and are strictly monitored by the FDA that establishes a new level of patient care and safety). Also, almost 75% of hospitals in the US outsource sterile compounding preparations to 503B facilities to ensure stability, cope up with drug shortages, obtain a ready-to-administer form of the drug, and extend shelf-life. Furthermore, the rising geriatric population and growing adoption of customized formulations over commercial products are expected to drive the growth of the US sterile compounding pharmacies market in the coming years.  


Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Sterile Compounding Pharmacies Market: Strategic Insights

sterile-compounding-pharmacies-market
Market Size Value inUS$ 3,968.70 million in 2021
Market Size Value byUS$ 6,198.59 million by 2028
Growth rateCAGR of 6.6% from 2021 to 2028.
Forecast Period2021-2028
Base Year2021
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Market Insights

Benefits of On-Site Sterile Compounding Drive Market Growth

On-site compounding and sterilization can prove vital in case of an intravenous solution intended to be customized as per the patient's need. On-site manufacturing allows the active pharmaceutical ingredient (API) to be introduced to human subjects during the starting phases of early clinical drug development. Sterile extemporaneous compounding offers a flexible option to the costly, extended development of parenteral investigational products designed by the Good Manufacturing (GMP) standards. Typically, parenterally administered API for clinical studies are manufactured under GMP conditions. This potentially reduces the time required for producing a finished product needed for specific dosing.

Moreover, compounding and filtering a formulation into a sterile intravenous solution successfully is met through strong collaboration with the pharmaceutical sponsor and clinical site pharmacists, where sterility testing can be conducted efficiently.

On-site sterile compounding has gained significant attention in the global market and is one of the most impacting factors responsible for market growth. This is due to sterile compounding pharmacists are focusing more on the latest research activities, innovative techniques, quality control rules, and getting the best ingredients to meet patients' needs. For example, the National Association of Boards of Pharmacy (NABP) announced receiving funding from the Food and Drug Administration (FDA) to develop a data-sharing system to improve oversight of sterile compounding pharmacies. This new system is expected to assist in collecting, managing, and sharing information related to sterile compounding in the US. The project also aims to reduce the risk of injury, favoring patients from drug products that have been improperly compounded.

Product-Based Insights

Based on product, the sterile compounding pharmacies market is bifurcated into injectable drugs and infusions. The injectable drugs segment would account for a larger market share during 2021–2028. Injectable drugs are among the highly preferred sterile compounding products due to their faster mode of action. To avoid any adverse effects on the patients, compounded injectable drugs (defined as drugs that are diluted, mixed, reconstituted, and prepared in an office) are compounded in such an environment where appropriate safeguards are maintained against the spread of disease and components of compounded drugs that are the appropriate strength and makeup. Market players are adopting organic and inorganic growth strategies for market growth. For instance, in September 2019, QuVa Pharma, Inc. declared a considerable increase in capacity for compounded sterile injectable preparations.

Sterile Compounding Pharmacies Market Report Scope

Route of Administration-Based Insights

Based on route of administration, the sterile compounding pharmacies market is segmented into intravenous, intramuscular, and subcutaneous. The intravenous segment held the largest share of the market in 2020 and is projected to continue its dominance during the forecast period. However, the intramuscular segment is estimated to register the highest CAGR in the market during the forecast period. The intramuscular (IM) route of drug delivery is the most common route for parenteral injection. Many antibiotics, preoperative sedatives, and narcotics are given through the intramuscular route. For instance, in February 2021, Biogen, announced that the US Food and Drug Administration (FDA) approved a new intramuscular (IM) injection for "Plegridy (peginterferon beta-1a) responsible for treating multiple sclerosis (MS).

Companies operating in the sterile compounding pharmacies market adopt the product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

Based on product, the sterile compounding pharmacies market is bifurcated into injectables and infusions.

Based on route of administration, the sterile compounding pharmacies market is segmented into intravenous, intramuscular, and subcutaneous

Sterile Compounding Pharmacies Market Size – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM


Company Profiles

  • Fagron, Inc.
  • Triangle Compounding Pharmacy
  • B. Braun Melsungen AG
  • PharMedium Healthcare Holdings, Inc.
  • Fresenius Kabi AG
  • Avella specialty Pharmacy
  • Pencol Compounding Pharmacy
  • Pavilion Compounding Pharmacy LLC
  • Pace Pharmacy
  • SandsRx
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Route of Administration, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

What are the driving factors for the sterile compounding pharmacies market across the globe?

Rising uptake of personalized medicines and the benefits of on-sterile compounding are the most significant factors responsible for the overall market growth.

Which segment led the sterile compounding pharmacies market?

Based on product type, injectable drugs took the forefront lead in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

Which route of administration segment held the largest revenue (US$ Mn) in the sterile compounding pharmacies market?

The intravenous segment dominated the global sterile compounding pharmacies market and accounted for the largest revenue of 2,954.51 Mn in 2021.

What is meant by the sterile compounding pharmacies market?

Sterile compounding pharmacies involve creating a medication in an environment free from viruses, bacteria, or any other potentially infectious microorganisms. Such a type of compounding is intended for medications that will be administered either through an IV or an injection.

What is the regional market scenario of the sterile compounding pharmacies market?

Global sterile compounding pharmacies market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for sterile compounding pharmacies market. The US is estimated to hold the largest share in the sterile compounding pharmacies market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of R&D activities is the key factor responsible for the Asia-Pacific regional growth for sterile compounding pharmacies accounting fastest growth of the region during the coming years.

Who are the key players in the sterile compounding pharmacies market?

Fagron, Inc., Triangle Compounding Pharmacy, B. Braun Melsungen AG, PharMedium Healthcare Holdings, Inc., Fresenious Kabi AG, Avella Specialty Pharmacy, Pencol Compounding Pharmacy, Pavilion Compounding Pharmacy, LLC., Pace Pharmacy, and SandsRx are among the leading companies operating in the global sterile compounding pharmacies market

Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Sterile Compounding Pharmacies Market – By Product

1.3.2 Global Sterile Compounding Pharmacies Market – By Route of Administration

1.3.3 Global Sterile Compounding Pharmacies Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Sterile Compounding Pharmacies Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Sterile Compounding Pharmacies Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Uptake of Personalized Medicines

5.1.2 Benefits of On-site Sterile Compounding

5.2 Market Restraints

5.2.1 Product Recalls and Stringent Regulatory Requirements

5.3 Market Opportunities

5.3.1 Development of Centralized or Regional Compounding Centers for Customized Formulation

5.4 Future Trends

5.4.1 Continued Support for Outsourcing Facilities and Manufacturing

5.5 Impact Analysis

6. Sterile Compounding Pharmacies Market– Global Analysis

6.1 Global Sterile Compounding Pharmacies Market Revenue Forecast and Analysis

6.2 Global Sterile Compounding Pharmacies Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Global Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028– by Product

7.1 Overview

7.2 Global Sterile Compounding Pharmacies Market, By Product, 2021 & 2028 (%)

7.3 Injectable Drugs

7.3.1 Overview

7.3.2 Injectable Drugs: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Infusions

7.4.1 Overview

7.4.2 Infusions: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

8. Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 – Route of Administration

8.1 Overview

8.2 Global Sterile Compounding Pharmacies Market Share by Route of Administration - 2021 & 2028 (%)

8.3 Subcutaneous

8.3.1 Overview

8.3.2 Subcutaneous: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

8.4 Intravenous

8.4.1 Overview

8.4.2 Intravenous: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

8.5 Intramuscular

8.5.1 Overview

8.5.2 Intramuscular: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

9. Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 – Geographical Analysis

9.1 North America: Sterile Compounding Pharmacies Market

9.1.1 Overview

9.1.2 North America: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3 North America: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)

9.1.4 North America: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)

9.1.5 North America: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)

9.1.5.1 US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.1 Overview

9.1.5.1.2 US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.3 US: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)

9.1.5.1.4 US: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)

9.1.5.2 Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.1 Overview

9.1.5.2.2 Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.3 Canada: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)

9.1.5.2.4 Canada: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)

9.1.5.3 Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.1 Overview

9.1.5.3.2 Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.3 Mexico: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)

9.1.5.3.4 Mexico: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)

9.2 Europe: Sterile Compounding Pharmacies Market

9.2.1 Overview

9.2.2 Europe: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.3 Europe: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

9.2.4 Europe: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

9.2.5 Europe: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)

9.2.5.1 Germany: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.1 Overview

9.2.5.1.2 Germany: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.3 Germany: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.4 Germany: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

9.2.5.2 France: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.1 Overview

9.2.5.2.2 France: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.3 France: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.4 France: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

9.2.5.3 UK: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.1 Overview

9.2.5.3.2 UK: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.3 UK: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.4 UK: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

9.2.5.4 Italy: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.1 Overview

9.2.5.4.2 Italy: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.3 Italy: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.4 Italy: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

9.2.5.5 Spain: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.1 Overview

9.2.5.5.2 Spain: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.3 Spain: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.4 Spain: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

9.2.5.6 Rest of Europe: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.1 Overview

9.2.5.6.2 Rest of Europe: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.3 Rest of Europe: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.4 Rest of Europe: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

9.3 Asia Pacific Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028

9.3.1 Overview

9.3.2 Asia Pacific Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.3.3 Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.3.4 Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

9.3.5 Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

9.3.5.1 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.1.1 Overview

9.3.5.1.2 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.1.3 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.3.5.1.4 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

9.3.5.2 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.2.1 Overview

9.3.5.2.2 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.2.3 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.3.5.2.4 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

9.3.5.3 India Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.3.1 Overview

9.3.5.3.2 India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.3.3 India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.3.5.3.4 India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

9.3.5.4 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.4.1 Overview

9.3.5.4.2 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.4.3 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.3.5.4.4 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

9.3.5.5 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.5.1 Overview

9.3.5.5.2 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.5.3 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.3.5.5.4 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

9.3.5.6 Rest of Asia Pacific: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.6.1 Overview

9.3.5.6.2 Rest of Asia Pacific: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.6.3 Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.3.5.6.4 Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

9.4 Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028

9.4.1 Overview

9.4.2 Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.4.3 Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

9.4.5 Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

9.4.5.1 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.1.1 Overview

9.4.5.1.2 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.1.3 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.4.5.1.4 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

9.4.5.2 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.2.1 Overview

9.4.5.2.2 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.2.3 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.4.5.2.4 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

9.4.5.3 South Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.3.1 Overview

9.4.5.3.2 South Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.3.3 South Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.4.5.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

9.4.5.4 Rest of Middle East and Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.4.1 Overview

9.4.5.4.2 Rest of Middle East and Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.4.3 Rest of Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

9.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

9.5 South and Central America: Sterile Compounding Pharmacies Market-Revenue and Forecasts To 2028

9.5.1 Overview

9.5.2 South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)

9.5.3 South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

9.5.4 South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

9.5.5 South and Central America: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

9.5.5.1 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

9.5.5.1.1 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

9.5.5.1.2 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

9.5.5.1.3 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

9.5.5.2 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

9.5.5.2.1 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

9.5.5.2.2 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

9.5.5.2.3 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

9.5.5.3 Rest of South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)

9.5.5.3.1 Rest of South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)

9.5.5.3.2 Rest of South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

9.5.5.3.3 Rest of South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

10. Impact Of COVID-19 Pandemic on Sterile Compounding Pharmacies Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

10.2 Europe: Impact Assessment of COVID-19 Pandemic

10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Sterile Compounding Pharmacies Market–Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Sterile Compounding Pharmacies Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 Fagron, Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Triangle Compounding Pharmacy

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 B. Braun Melsungen AG

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 PharMEDium Healthcare Holdings, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Fresenius Kabi AG

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Avella specialty pharmacy

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Pencol Compounding Pharmacy

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Pavilion Compounding Pharmacy, LLC.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Pace Pharmacy

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 SandsRx

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 3. US Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 4. US Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 5. Canada: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 6. Canada Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 7. Mexico: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8. Mexico Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 9. Europe: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 10. Europe: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 11. Germany: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 12. Germany: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 13. France: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 14. France: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 15. UK: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 16. UK: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 17. Italy: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 18. Italy: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 19. Spain: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 20. Spain: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 21. Rest of Europe: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 22. Rest of Europe: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 23. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million).

Table 24. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 25. Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 26. Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 27. China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 28. China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 29. India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 30. India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 31. South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 32. South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 33. Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 34. Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 35. Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 36. Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 37. Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 38. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 39. UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 40. UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 41. Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 42. Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 43. South Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 44. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 45. Rest of Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 46. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 47. South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

Table 48. South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 49. Brazil Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

Table 50. Brazil Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 51. Argentina Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

Table 52. Argentina Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 53. Rest of South and Central America Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

Table 54. Rest of South and Central America Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 55. Organic Developments in the Sterile Compounding Pharmacies Market

Table 56. Inorganic Developments in the Sterile Compounding Pharmacies Market

Table 57. Glossary of Terms

LIST OF FIGURES

Figure 1. Sterile Compounding Pharmacies Market Segmentation

Figure 2. Sterile Compounding Pharmacies Market, By Region

Figure 3. Global Sterile Compounding Pharmacies Market Overview

Figure 4. Injectable Drugs Segment Held Largest Share of Product Segment in Sterile Compounding Pharmacies Market

Figure 5. North America is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Sterile Compounding Pharmacies Market, by Geography (US$ Million)

Figure 7. Global Sterile Compounding Pharmacies Market- Leading Country Markets (US$ Million)

Figure 8. Global Sterile Compounding Pharmacies Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East And Africa: PEST Analysis

Figure 13. South And Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Impact Analysis of Drivers and Restraints About Sterile Compounding Pharmacies Market

Figure 16. Global Sterile Compounding Pharmacies Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 17. Global Sterile Compounding Pharmacies Market – By Geography Forecast and Analysis – 2021 - 2028

Figure 18. Market Positioning of Key Players in Global Sterile Compounding Pharmacies Market

Figure 19. Global Sterile Compounding Pharmacies Market, by Product, 2021 & 2028 (%)

Figure 20. Injectable Drugs: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Infusions: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Global Sterile Compounding Pharmacies Market Share by Route of Administration - 2021 & 2028 (%)

Figure 23. Subcutaneous: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. Intravenous: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Intramuscular: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. North America: Sterile Compounding Pharmacies Market, by Key Country – Revenue (2021) (US$ Million)

Figure 27. North America Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. North America: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)

Figure 29. US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Europe: Sterile Compounding Pharmacies Market, by Key Country – Revenue (2021) (US$ Million)

Figure 33. Europe: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

Figure 34. Europe: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)

Figure 35. Germany: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. France: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. UK: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Italy: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. Spain: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40. Rest of Europe: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. Asia Pacific Sterile Compounding Pharmacies Market Overview, by Country (2021)

Figure 42. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 43. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45. China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46. India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 47. South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 48. Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 49. Rest of Asia Pacific: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 50. Middle East & Africa Sterile Compounding Pharmacies Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 51. Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 52. Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

Figure 53. UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 54. Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 55. South Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 56. Rest of Middle East and Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 57. South and Central America: Sterile Compounding Pharmacies Market, Revenue Overview, by Country, 2021 (US$ Million)

Figure 58. South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

Figure 59. South and Central America: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

Figure 60. Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

Figure 61. Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

Figure 62. Rest of South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)

Figure 63. Impact of COVID-19 Pandemic in North American Country Markets

Figure 64. Impact of COVID-19 Pandemic in European Country Markets

Figure 65. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 66. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 67. Impact of COVID-19 Pandemic on Sterile Compounding Pharmacies Market in South and Central American Countries

Figure 68. Growth Strategies in the Sterile Compounding Pharmacies Market (%)

The List of Companies - sterile compounding pharmacies market

  1. Fagron, Inc.
  2. Triangle Compounding Pharmacy
  3. B. Braun Melsungen AG
  4. PharMedium Healthcare Holdings, Inc.
  5. Fresenious Kabi AG
  6. Avella Specialty Pharmacy
  7. Pencol Compounding Pharmacy
  8. Pavilion Compounding Pharmacy, LLC.
  9. Pace Pharmacy
  10. SandsRx                                    

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..